SELECT MED HLDGS CORP's ticker is SEM and the CUSIP is 81619Q105. A total of 195 filers reported holding SELECT MED HLDGS CORP in Q2 2019. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,976 | -23.0% | 117,766 | -2.9% | 0.07% | -16.0% |
| Q2 2023 | $3,866 | +12.7% | 121,329 | -8.6% | 0.08% | +11.0% |
| Q1 2023 | $3,431 | +4.1% | 132,742 | 0.0% | 0.07% | -1.4% |
| Q4 2022 | $3,296 | -99.9% | 132,742 | -15.8% | 0.07% | -11.9% |
| Q3 2022 | $3,486,000 | -6.4% | 157,742 | 0.0% | 0.08% | 0.0% |
| Q2 2022 | $3,726,000 | -1.5% | 157,742 | 0.0% | 0.08% | +12.0% |
| Q1 2022 | $3,784,000 | -29.1% | 157,742 | -13.2% | 0.08% | -15.7% |
| Q4 2021 | $5,340,000 | -18.7% | 181,642 | 0.0% | 0.09% | -24.6% |
| Q3 2021 | $6,570,000 | -14.4% | 181,642 | 0.0% | 0.12% | -12.6% |
| Q2 2021 | $7,676,000 | -4.5% | 181,642 | -22.9% | 0.14% | +0.7% |
| Q1 2021 | $8,036,000 | -1.6% | 235,672 | -20.2% | 0.13% | -10.7% |
| Q4 2020 | $8,167,000 | +32.8% | 295,272 | 0.0% | 0.15% | +11.1% |
| Q3 2020 | $6,148,000 | +40.2% | 295,272 | -0.8% | 0.14% | +32.4% |
| Q2 2020 | $4,385,000 | -1.8% | 297,672 | 0.0% | 0.10% | -15.7% |
| Q1 2020 | $4,465,000 | -44.6% | 297,672 | -13.7% | 0.12% | -28.0% |
| Q4 2019 | $8,054,000 | +20.7% | 345,070 | -14.3% | 0.17% | +28.2% |
| Q3 2019 | $6,671,000 | +59.6% | 402,570 | +52.8% | 0.13% | +50.6% |
| Q2 2019 | $4,180,000 | +12.6% | 263,400 | 0.0% | 0.09% | +11.5% |
| Q1 2019 | $3,711,000 | -15.1% | 263,400 | +1.7% | 0.08% | +52.9% |
| Q4 2018 | $4,371,000 | +83.4% | 259,000 | +100.0% | 0.05% | -1.9% |
| Q3 2018 | $2,383,000 | -35.4% | 129,500 | -36.3% | 0.05% | -35.0% |
| Q2 2018 | $3,688,000 | +5.2% | 203,200 | 0.0% | 0.08% | 0.0% |
| Q1 2018 | $3,505,000 | -2.3% | 203,200 | 0.0% | 0.08% | +1.3% |
| Q4 2017 | $3,586,000 | -22.1% | 203,200 | -15.3% | 0.08% | -15.1% |
| Q3 2017 | $4,606,000 | +25.1% | 239,900 | 0.0% | 0.09% | +19.2% |
| Q2 2017 | $3,682,000 | +1.9% | 239,900 | -11.4% | 0.08% | +5.4% |
| Q1 2017 | $3,614,000 | -3.0% | 270,700 | -3.7% | 0.07% | -6.3% |
| Q4 2016 | $3,726,000 | -1.8% | 281,200 | 0.0% | 0.08% | 0.0% |
| Q3 2016 | $3,796,000 | +24.2% | 281,200 | 0.0% | 0.08% | +17.9% |
| Q2 2016 | $3,057,000 | – | 281,200 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Standard LLC | 213,703 | $5,524,223 | 5.60% |
| Camber Capital Management LP | 4,800,000 | $124,080 | 3.82% |
| Hood River Capital Management LLC | 2,693,137 | $69,618,000 | 2.25% |
| Smith, Graham & Co., Investment Advisors, LP | 434,878 | $11,241,596 | 1.37% |
| Sivik Global Healthcare LLC | 107,838 | $2,788 | 1.20% |
| Capital Impact Advisors, LLC | 33,173 | $857,522 | 1.05% |
| DENALI ADVISORS LLC | 85,772 | $2,217,206 | 0.92% |
| CLOUGH CAPITAL PARTNERS L P | 297,500 | $7,690,375 | 0.83% |
| Huber Capital Management LLC | 127,603 | $3,298,537 | 0.82% |
| Nebula Research & Development LLC | 12,442 | $321,626 | 0.57% |